King Street Capital Management’s Medifast MED Stock Holding History

King Street Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,000	Closed	-$217K	–	24
2022 Q3	$217K	Buy	+2,000	New	+$287K	0.04%	31
2022 Q2	–	Sell	-3,200	Closed	-$546K	–	39
2022 Q1	$546K	Buy	+3,200	New	+$603K	0.05%	46
2021 Q3	–	Sell	-2,900	Closed	-$821K	–	91
2021 Q2	$821K	Buy	2,900 +300	+12%	+$81.3K	0.07%	70
2021 Q1	$551K	Buy	+2,600	New	+$622K	0.04%	76

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

King Street Capital Management's MED Position: Q4 2022 in Review

King Street Capital Management sold out of Medifast (MED) in Q4 2022, closing a stake of 2,000 shares — an estimated $217K sold.

King Street Capital Management first reported a position in MED in Q1 2021 and held it in 4 quarters. The position peaked at $821K in Q2 2021. 277 funds tracked by Wall St. Rank hold MED as of Q4 2022.

King Street Capital Management reported no remaining Medifast position as of Q4 2022 after selling out during the quarter.
King Street Capital Management sold 2,000 Medifast shares in Q4 2022, an estimated $217K.
King Street Capital Management first reported a position in Medifast in Q1 2021 and held it in 4 quarters.
King Street Capital Management's Medifast position peaked at $821K in Q2 2021.
277 funds tracked by Wall St. Rank held Medifast as of Q4 2022.

Based on King Street Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.